Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Under the topic HORIZON-HLTH-2025-01-DISEASE-01 should aim to deliver results that are directed, tailored towards and contributing to most of the following expected outcomes:

• Researchers and developers make the best use of the state-of-the-art knowledge and resources for an effective development of new treatment options for patients suffering from difficult-to-treat infections.
• Healthcare professionals and people living with difficult-to-treat infections are ultimately provided with the availability of clinically useful phage therapies.
• Regulators are provided with quantifiable, verifiable and replicable data on safety and efficacy of phage therapy for human use and move faster towards market approval of novel phage-based therapies against antimicrobial resistant infections.
• Citizens are engaged and informed on innovative phage-based treatments as alternative therapeutic options complementary to antibiotics.

Interested parties can find more information and apply on the Funding and Tenders Portal.